BILL NUMBER: SB 1438 AMENDED
BILL TEXT
AMENDED IN SENATE APRIL 10, 2014
INTRODUCED BY Senator Pavley
FEBRUARY 21, 2014
An act to amend Section 1714.22 of the Civil Code, and to
amend Section 11601 Sections 1797.197
and 11601 of the Health and Safety Code, relating to controlled
substances.
LEGISLATIVE COUNSEL'S DIGEST
SB 1438, as amended, Pavley. Controlled substances:
research. opioid antagonists.
(1) Existing law authorizes a licensed health care provider who is
permitted by law to prescribe an opioid antagonist and is acting
with reasonable care to prescribe and subsequently dispense or
distribute an opioid antagonist for the treatment of an opioid
overdose to a person at risk of an opioid-related overdose or a
family member, friend, or other person in a position to assist a
person at risk of an opioid-related overdose. Under existing law,
licensed health care providers are authorized to issue standing
orders for the distribution of an opioid antagonist to a person at
risk of an opioid-related overdose or to a family member, friend, or
other person in a position to assist the person at risk. Existing law
also authorizes licensed health care providers to issue standing
orders for the administration of an opioid antagonist by a family
member, friend, or other person in a position to assist a person
experiencing or suspected of experiencing an opioid overdose.
Existing law provides that a licensed health care provider who
acts with reasonable care and issues a prescription for, or an order
for the administration of, an opioid antagonist to a person
experiencing or suspected of experiencing an opioid overdose is not
subject to professional review, liable in a civil action, or subject
to criminal prosecution for issuing the prescription or order. Under
existing law, a person who is not otherwise licensed to administer an
opioid antagonist, but who meets other specified conditions, is not
subject to professional review, liable in a civil action, or subject
to criminal prosecution for administering an opioid antagonist.
This bill would clarify that peace officers are included among the
persons authorized to receive and distribute opioid antagonists as
described above.
(2) Existing law, the Emergency Medical Services System and the
Prehospital Emergency Medical Care Personnel Act, establishes the
Emergency Medical Services Authority (EMSA), which is responsible for
the coordination and integration of all state agencies concerning
emergency medical services. Under existing law, EMSA is required to
establish training and standards, and promulgate regulations, for all
prehospital emergency care personnel, as defined, regarding the
characteristics and method of assessment and treatment of
anaphylactic reactions and the use of epinephrine.
This bill would require EMSA to establish training and standards,
and promulgate regulations, for all prehospital emergency care
personnel, as defined, regarding the use and administration of
naloxone hydrochloride and other opioid antagonists. The bill would
also authorize a local EMS agency to establish training and
standards, and promulgate regulations, in lieu of those developed and
promulgated by EMSA, for all prehospital emergency care personnel
under the jurisdiction of that local EMS agency regarding the use and
administration of naloxone hydrochloride and other opioid
antagonists. The bill would specify that both of those types of
trainings satisfy the requirements described above allowing for
immunity from criminal and civil liability for administering an
opioid antagonist.
Existing
(3) Existing law, the Uniform
Controlled Substances Act, requires the Attorney General to encourage
research on the misuse and abuse of controlled substances, and, in
connection with that research, and in furtherance of the enforcement
of the act, authorizes the Attorney General to undertake specific
acts, including developing new or improved approaches, techniques,
systems, equipment, and devices to strengthen the enforcement of the
act.
This bill would additionally permit the Attorney General, in
connection with that research, and in furtherance of the enforcement
of the act, to authorize hospitals and trauma centers to share
information with local law enforcement agencies and local
emergency medical services agencies about controlled
substances. The bill would limit the data that may be provided by
hospitals and trauma centers to the number of overdoses and the
substances suspected as the primary cause of the overdoses. The bill
would require that the information shared be shared in a manner that
ensures complete patient confidentiality.
Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: no.
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:
SECTION 1. Section 1714.22 of the Civil
Code is amended to read:
1714.22. (a) For purposes of this section, the following
definitions shall apply:
(1) "Opioid antagonist" means naloxone hydrochloride that is
approved by the federal Food and Drug Administration for the
treatment of an opioid overdose.
(2) "Opioid overdose prevention and treatment training program"
means any program operated by a local health jurisdiction or that is
registered by a local health jurisdiction to train individuals to
prevent, recognize, and respond to an opiate overdose, and that
provides, at a minimum, training in all of the following:
(A) The causes of an opiate overdose.
(B) Mouth to mouth resuscitation.
(C) How to contact appropriate emergency medical services.
(D) How to administer an opioid antagonist.
(b) A licensed health care provider who is authorized by law to
prescribe an opioid antagonist may, if acting with reasonable care,
prescribe and subsequently dispense or distribute an opioid
antagonist to a person at risk of an opioid-related overdose or to a
family member, friend, peace officer, or other person in a
position to assist a person at risk of an opioid-related overdose.
(c) (1) A licensed health care provider who is authorized by law
to prescribe an opioid antagonist may issue standing orders for the
distribution of an opioid antagonist to a person at risk of an
opioid-related overdose or to a family member, friend, peace
officer, or other person in a position to assist a person at
risk of an opioid-related overdose.
(2) A licensed health care provider who is authorized by law to
prescribe an opioid antagonist may issue standing orders for the
administration of an opioid antagonist to a person at risk of an
opioid-related overdose by a family member, friend, peace
officer, or other person in a position to assist a person
experiencing or reasonably suspected of experiencing an opioid
overdose.
(d) (1) A person who is prescribed or possesses an opioid
antagonist pursuant to a standing order shall receive the training
provided by an opioid overdose prevention and treatment training
program.
(2) A person who is prescribed an opioid antagonist directly from
a licensed prescriber shall not be required to receive training from
an opioid prevention and treatment training program.
(e) A licensed health care provider who acts with reasonable care
shall not be subject to professional review, be liable in a civil
action, or be subject to criminal prosecution for issuing a
prescription or order pursuant to subdivision (b) or (c).
(f) Notwithstanding any other law, a person who possesses or
distributes an opioid antagonist pursuant to a prescription or
standing order shall not be subject to professional review, be liable
in a civil action, or be subject to criminal prosecution for this
possession or distribution. Notwithstanding any other law, a person
not otherwise licensed to administer an opioid antagonist, but
trained as required under paragraph (1) of subdivision (d), who acts
with reasonable care in administering an opioid antagonist, in good
faith and not for compensation, to a person who is experiencing or is
suspected of experiencing an overdose shall not be subject to
professional review, be liable in a civil action, or be subject to
criminal prosecution for this administration.
SEC. 2. Section 1797.197 of the Health
and Safety Code is amended to read:
1797.197. (a) The authority shall establish
training and standards for all prehospital emergency care personnel,
as defined pursuant to in paragraph
(2) of subdivision (a) of Section 1797.189, regarding the
characteristics and method of assessment and treatment of
anaphylactic reactions and the use of epinephrine. The
authority shall promulgate regulations regarding these matters for
use by all prehospital emergency care personnel.
(b) (1) The authority shall establish training and standards for
all prehospital emergency care personnel, as defined in paragraph (2)
of subdivision (a) of Section 1797.189, regarding the use and
administration of naloxone hydrochloride and other opioid
antagonists. The authority shall promulgate regulations regarding
these matters for use by all prehospital emergency care personnel.
The authority may designate existing training and standards for the
use and administration of naloxone hydrochloride or another opioid
antagonist to satisfy the requirements of this section.
(2) A local EMS agency may develop its own training and standards,
and may promulgate regulations, in lieu of the training and
standards and regulations developed by the authority pursuant to
paragraph (1), regarding the use and administration of naloxone
hydrochloride and other opioid antagonists by prehospital emergency
care personnel under the jurisdiction of that local EMS agency.
(3) The training described in paragraphs (1) and (2) shall satisfy
the requirements of paragraph (1) of subdivision (d) of Section
1714.22 of the Civil Code.
SECTION 1. SEC. 3. Section 11601 of
the Health and Safety Code is amended to read:
11601. The Attorney General shall encourage research on misuse
and abuse of controlled substances. In connection with the research,
and in furtherance of the enforcement of this division, he or she may
do all of the following:
(a) Develop new or improved approaches, techniques, systems,
equipment, and devices to strengthen the enforcement of this
division.
(b) Enter into contracts with public agencies, institutions of
higher education, and private organizations or individuals for the
purpose of conducting demonstrations or special projects that bear
directly on misuse and abuse of controlled substances.
(c) (1) Authorize hospitals and trauma centers to share
information with local law enforcement agencies and local
emergency medical services agencies about controlled substance
overdose trends.
(2) The information provided by hospitals and trauma centers
pursuant to this subdivision shall include only the number of
overdoses and the substances suspected as the primary cause of the
overdoses. Any information shared pursuant to this subdivision shall
be shared in a manner that ensures complete patient confidentiality.